143 related articles for article (PubMed ID: 9847048)
1. The routine use of atypical antipsychotic agents: maintenance treatment.
Kinon BJ
J Clin Psychiatry; 1998; 59 Suppl 19():18-22. PubMed ID: 9847048
[TBL] [Abstract][Full Text] [Related]
2. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
[TBL] [Abstract][Full Text] [Related]
3. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine in the long-term treatment of schizophrenia.
Kane J
Br J Psychiatry Suppl; 1999; (37):26-9. PubMed ID: 10211138
[TBL] [Abstract][Full Text] [Related]
5. Marked reduction of tardive dyskinesia with olanzapine.
Littrell KH; Johnson CG; Littrell S; Peabody CD
Arch Gen Psychiatry; 1998 Mar; 55(3):279-80. PubMed ID: 9510225
[No Abstract] [Full Text] [Related]
6. Tardive dyskinesia in older patients.
Jeste DV
J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
[TBL] [Abstract][Full Text] [Related]
7. The treatment of tardive dyskinesia and tardive dystonia.
Simpson GM
J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
[TBL] [Abstract][Full Text] [Related]
8. Risperidone and tardive dyskinesia: a case of blepharospasm.
Mullen A
Aust N Z J Psychiatry; 2000 Oct; 34(5):879-80. PubMed ID: 11037386
[No Abstract] [Full Text] [Related]
9. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD
Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia in affective disorders.
Kane JM
J Clin Psychiatry; 1999; 60 Suppl 5():43-7; discussion 48-9. PubMed ID: 10192407
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine for the treatment of tardive dyskinesia.
Almeida OP
J Clin Psychiatry; 1998 Jul; 59(7):380-1. PubMed ID: 9714267
[No Abstract] [Full Text] [Related]
12. Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine.
Ipekçi S; Birsöz S
Eur Psychiatry; 2001 Jun; 16(4):259-60. PubMed ID: 11418277
[No Abstract] [Full Text] [Related]
13. Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases.
Agarwal V; Kumar P
J Clin Psychiatry; 2001 Apr; 62(4):298-9. PubMed ID: 11379849
[No Abstract] [Full Text] [Related]
14. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
[TBL] [Abstract][Full Text] [Related]
15. Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine.
Lykouras L; Agelopoulos E; Tzavellas E
Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):815-7. PubMed ID: 12188112
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic measures in tardive dyskinesia].
Tegeler J; Wöller W
Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
[TBL] [Abstract][Full Text] [Related]
17. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
[TBL] [Abstract][Full Text] [Related]
18. Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication.
Moritz S; Woodward TS; Krausz M; Naber D;
Int Clin Psychopharmacol; 2002 Jan; 17(1):41-4. PubMed ID: 11800506
[TBL] [Abstract][Full Text] [Related]
19. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
Csernansky JG; Mahmoud R; Brenner R;
N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
[TBL] [Abstract][Full Text] [Related]
20. One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics.
Patel NC; Dorson PG; Edwards N; Mendelson S; Crismon ML
Psychiatr Serv; 2002 Jul; 53(7):891-3. PubMed ID: 12096177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
